Case 17-2024: A 45-Year-Old Woman with Metastatic Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Case 17-2024: A 45-Year-Old Woman with Metastatic Breast Cancer

Published:2024-06-06 Issue:21 Volume:390 Page:2011-2022
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Vidula Neelima¹,Rodriguez Karen¹,Wong Alexandra K.¹,Boyraz Baris¹

Affiliation:

1. From the Departments of Medicine (N.V., A.K.W.), Radiology (K.R.), and Pathology (B.B.), Massachusetts General Hospital, and the Departments of Medicine (N.V., A.K.W.), Radiology (K.R.), and Pathology (B.B.), Harvard Medical School — both in Boston.

Publisher

Massachusetts Medical Society

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMcpc2309499

Reference41 articles.

1. Trastuzumab deruxtecan (T-DXd) versus treatment of physician’s choice (TPC) in patients (pts) with HER2-low unresectable and/or metastatic breast cancer (mBC): Results of DESTINY-Breast04, a randomized, phase 3 study.

2. TROPiCS-02: A Phase III study investigating sacituzumab govitecan in the treatment of HR+/HER2- metastatic breast cancer

3. Antibody drug conjugate: the “biological missile” for targeted cancer therapy

4. Trastuzumab Deruxtecan: Changing the Destiny of HER2 Expressing Solid Tumors

5. Trophoblast Cell Surface Antigen 2 gene (TACSTD2) expression in primary breast cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP